TG Therapeutics Inc (TGTX) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ... [Yahoo! Finance]
TG Therapeutics, Inc. (TGTX)
Last tg therapeutics, inc. earnings: 11/12 07:34 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.tgtherapeutics.com
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus Total Global Revenue: Approximately $616 million for 2025. BRIUMVI US Net Sales: $594 million for 2025. Fourth Quarter Revenue: $183 million, representing 92% year-over-year growth and 20% sequential growth from Q3. US BRIUMVI Net Product Revenue (Q4): $182.7 million. Total Net Product Revenue (Q4): $189.1 million, including $6.4 million from ex-US sales. Operating Expenses (2025): Approximately $328 million. Operating Income (2025): $123 million. Net Income (Q4): $23 million or $0.14 per diluted share. Net Income (2025): $447.2 million or $2.77 per diluted share, including a non-recurring income tax benefit of approximately $340 million. Cash and Investments (End of 2025): Approximately $200 million. Accounts Receivable (End of 2025): $300 million. Inventory (End of 2025): $140 million. Share Repurchase Program: Completed $100 million program, with an additional $100 million authorized. 2026 Revenue Guidance: US BR
Show less
Read more
Impact Snapshot
Event Time:
TGTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TGTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TGTX alerts
High impacting TG Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
TGTX
News
- TG Therapeutics (TGTX) Reports Financial Results for Q4 and Full Year 2025 [Yahoo! Finance]Yahoo! Finance
- TG Therapeutics Five Year BRIUMVI Data And What It Means For Valuation [Yahoo! Finance]Yahoo! Finance
- TG Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- TG Therapeutics (TGTX) Q4 2025 Earnings Transcript [Yahoo! Finance]Yahoo! Finance
- TG Therapeutics outlines $825M–$850M BRIUMVI 2026 guidance while accelerating subcutaneous program [Seeking Alpha]Seeking Alpha
TGTX
Earnings
- 2/26/26 - Miss
TGTX
Sec Filings
- 2/27/26 - Form 10-K
- 2/26/26 - Form 8-K
- 1/29/26 - Form 4
- TGTX's page on the SEC website